Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
To
OTC Journal Members:
 |
Profit Alert: Sell Half of
FXI And EWZ For 40% Gains |
|
Congratulations if you took advantage
of the triple in UFood Grill (OTC BB: UFFC) last week. I
suggested taking part or all your profits when the stock traded up over
$.30 in just two trading days from my $.12 entry level. As I said- easy
money. Now, the easy money has been made. I want to reinforce a strong
buy recommendation at $.20- down 45% from this week's high if you
see it there. SSL- $.17 if you want to preserve capital in
a down market.
It's time to take some profits in
two other situations, and go long another if you like to trade:
-
Sell 50% of your FXI (China Large
Cap ETF): if you followed my suggestion and bought at $25 last
month, we are now trading at $30 plus. You now have a short term profit
of 20% cash- 40% gain if you bought on margin. Long term I believe it's
a lot higher, which is why I'm suggesting selling only half in case it
wants to roll higher.
-
Sell 50% of your EWZ (Brazil Large
Cap ETF): Just like China- I recommended this one at $35 and it
closed today at $41. 17% in cash accounts, $34% in margin accounts. My
long term target is $67, but lock in some short term gains now.
-
Go long FAZ (Triple Leveraged
Short ETF on Financials) at $19 or below with a stop
loss at $18. This is a bet the financials are due for a correction to the
downside, and this security is highly volatile and extremely treacherous.
Look for a 3 or 4 point move to the upside, then get out. Take your loss
quickly if it goes against you. This idea is for skilled traders only.
This is a very scary security, and this trade is only suggested if you're
in a position to monitor it regularly. The market could go higher, but
money appears to be rotating out of overbought financials into tech, which
would make FAZ go up.
There will have a new idea in the small
cap arena coming out tomorrow or Monday. Stay Tuned.
Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
|
Click Here to View the OTC Journal Disclosure
|
|
To subscribe to our newsletter, please enter your email address below.
Quotes are delayed 20 minutes.

|